MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
STAAR Surgical Company DSO Ratio 2011-2026 | STAA
Annual DSO Ratio STAAR Surgical Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | 89 | 68 | 59 | 79.5 | - | 81.6 | 86.6 | 80.4 | 57.3 | 57.1 | - | 50.9 | 54.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 100 | 50.9 | 72 |
Quarterly DSO Ratio STAAR Surgical Company
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.5 | 76.6 | 126 | - | 102 | 73 | 94 | - | 117 | 78.1 | 78.2 | - | 70.9 | 61.8 | 65.4 | 66.1 | 70.8 | 60.3 | 58.2 | 85.7 | 79 | 95.9 | 44.7 | - | 74.5 | 68.5 | 73.6 | 75.9 | 74.5 | 69.8 | 73.8 | 69.6 | 77.9 | 83.3 | 80.1 | 66 | 74.4 | 71.1 | 64.9 | 65.6 | 61.5 | 57.5 | 52.7 | 53.9 | 61.1 | 54.2 | 25.1 | - | 52.8 | 47.6 | 43.5 | 47.3 | 49.1 | 48.9 | 51.9 | 50.6 | 54.3 | 51 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 126 | 25.1 | 67.5 |
DSO Ratio of other stocks in the Medical instruments industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
204 | $ 20.66 | 1.27 % | $ 10.5 B | USA |
 |
Becton, Dickinson and Company
BDX
|
50.4 | $ 205.09 | 1.16 % | $ 59 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
131 | $ 8.15 | -7.6 % | $ 164 M | USA |
 |
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
53.3 | $ 0.66 | -1.92 % | $ 28 M | USA |
 |
iRhythm Technologies
IRTC
|
43.6 | $ 188.16 | 0.41 % | $ 5.87 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | USA |
 |
Masimo Corporation
MASI
|
12.7 | $ 138.18 | 0.8 % | $ 7.36 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
54.9 | $ 84.98 | 2.36 % | $ 4.28 B | USA |
 |
OraSure Technologies
OSUR
|
62.8 | $ 2.65 | 5.38 % | $ 197 M | USA |
 |
Alcon
ALC
|
71 | $ 80.67 | -0.38 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
115 | $ 6.85 | 3.24 % | $ 37.4 M | USA |
 |
AtriCure
ATRC
|
44.3 | $ 42.59 | 1.96 % | $ 2 B | USA |
 |
electroCore
ECOR
|
12.7 | $ 5.15 | 6.19 % | $ 28.4 K | USA |
 |
ICU Medical
ICUI
|
26.4 | $ 152.88 | 1.7 % | $ 3.73 B | USA |
 |
AngioDynamics
ANGO
|
54 | $ 10.02 | -8.29 % | $ 409 M | USA |
 |
The Cooper Companies
COO
|
68.9 | $ 83.38 | -0.63 % | $ 16.6 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
68.6 | $ 260.64 | 0.52 % | $ 25.7 B | USA |
 |
Glaukos Corporation
GKOS
|
44 | $ 114.49 | 0.43 % | $ 5.55 B | USA |
 |
InfuSystem Holdings
INFU
|
53.6 | $ 8.9 | -0.11 % | $ 184 M | USA |
 |
Repro Med Systems
KRMD
|
48.7 | $ 5.79 | 3.02 % | $ 264 M | USA |
 |
LeMaitre Vascular
LMAT
|
43.2 | $ 85.05 | 1.55 % | $ 1.91 B | USA |
 |
Intuitive Surgical
ISRG
|
51.5 | $ 586.15 | -1.03 % | $ 208 B | USA |
 |
Merit Medical Systems
MMSI
|
49.5 | $ 93.33 | 1.83 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
132 | $ 58.5 | 1.39 % | $ 212 M | USA |
 |
Nephros
NEPH
|
35.7 | $ 5.07 | -1.74 % | $ 52.7 M | USA |
 |
Microbot Medical
MBOT
|
167 | $ 2.19 | 3.55 % | $ 22.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
16.7 | $ 0.29 | 2.24 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
56 | $ 23.52 | 2.53 % | $ 4.05 B | USA |
 |
Pro-Dex
PDEX
|
83.1 | $ 41.83 | 4.47 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
15.9 | $ 14.71 | -3.26 % | $ 707 M | USA |
 |
Repligen Corporation
RGEN
|
69.4 | $ 165.12 | -2.32 % | $ 9.2 M | USA |
 |
ResMed
RMD
|
60.7 | $ 250.85 | 1.07 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.91 | -1.97 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
60.8 | $ 2.57 | -1.35 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
102 | $ 0.76 | -0.53 % | $ 22.8 M | USA |
 |
Teleflex Incorporated
TFX
|
54.1 | $ 110.0 | -13.07 % | $ 5.15 B | USA |
 |
West Pharmaceutical Services
WST
|
67.1 | $ 274.0 | -1.62 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
64.3 | $ 12.53 | 1.25 % | $ 2.55 B | USA |